Hepatitis B surface antigenemia (HBsAg) among pregnant women in southern Nigeria.

Background: Hepatitis B virus (HBV) infection is one of the most common public health problems worldwide. Over one million people die annually of HBV- related chronic liver disease. Maternal to fetal transmission from chronic carriers exceeds 90% and accounts for up to 40% of the world’s chronic carriers in endemic areas. Methods: This was a descriptive study which involved Serial recruitment of 836 women attending the antenatal clinic at a health facility in Cross-River State, Nigeria from 1st January to 30th June 2010. HBsAg screening was done using an ELISA test. Results: Fifty five (6.6%) of the 836 women screened tested positive for HBsAg. The mean age and parity of sero-positive subjects was 26.9 ±5.0 (range 18-38 years) and 2.2±1.2 (0 to 5) respectively. The prevalence was more in women who were farmers (29.1%) and those with either none or low level of formal education (67.2%). Conclusion: Sero-prevalence of 6.6% among pregnant women is reported. Women education, economic empowerment and public enlightenment programmes focused on modification of risky social lifestyle is recommended. Efforts to promote routine screening of pregnant women, immunization and vaccination of infants should be sustained. Keywords: Sero-prevalence, Hepatitis B virus, routine screening, immunization African Health Sciences 2013; 13(4): 1139 - 1143

[1]  A. Olokoba,et al.  Hepatitis B virus infection amongst pregnant women in North-eastern Nigeria- a call for action. , 2011, Nigerian journal of clinical practice.

[2]  K. Rabiu,et al.  Risk factors for hepatitis B virus infection among pregnant women in Lagos, Nigeria , 2010, Acta obstetricia et gynecologica Scandinavica.

[3]  S. Bhutta,et al.  Prevalence of hepatitis B and C: A Jinnah Postgraduate Medical Centre experience , 2009, The journal of obstetrics and gynaecology research.

[4]  F. Okonofua,et al.  The prevalence of dual human immunodeficiency virus/hepatitis C virus (HIV/HCV) infection in asymptomatic pregnant women in Benin City, Nigeria. , 2009, African journal of reproductive health.

[5]  Uyar Yavuz,et al.  Seroprevalence of Hepatitis B Virus among Pregnant Women in Northern Turkey , 2009 .

[6]  Hung‐Chih Yang,et al.  Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double‐blind, placebo‐controlled study , 2009, Journal of viral hepatitis.

[7]  Y. Bacq [Hepatitis B and pregnancy]. , 2008, Gastroenterologie clinique et biologique.

[8]  Mei-Hwei Chang,et al.  Hepatitis B virus infection. , 2007, Seminars in fetal & neonatal medicine.

[9]  H. Onah,et al.  Risk factors for hepatitis B infection during pregnancy in a Nigerian obstetric population , 2006, Journal of obstetrics and gynaecology : the journal of the Institute of Obstetrics and Gynaecology.

[10]  A. Bassi,et al.  Sero-prevalence of hepatitis B surface antigen among primary school pupils in rural Hawal valley, Borno State, Nigeria , 2005 .

[11]  Y. Al-Mazrou,et al.  Serosurvey of hepatitis B surface antigen in pregnant Saudi women. , 2005, Eastern Mediterranean health journal = La revue de sante de la Mediterranee orientale = al-Majallah al-sihhiyah li-sharq al-mutawassit.

[12]  J. Wands,et al.  Hepatitis B Virus e Antigen Variants , 2005, International journal of medical sciences.

[13]  K. Pan,et al.  Efficacy and safety of lamivudine treatment for chronic hepatitis B in pregnancy. , 2004, World journal of gastroenterology.

[14]  L. Zou,et al.  Interruption of HBV intrauterine transmission: a clinical study. , 2003, World journal of gastroenterology.

[15]  F. Denis,et al.  Virus des hepatites : transmission mere-enfant , 2002 .

[16]  S. Tosun,et al.  THE IMMUNIZATION OF BABIES BORN OF HBsAg POSITİVE PREGNANT WOMEN , 2002 .

[17]  W. Maddrey,et al.  Hepatitis B--an important public health issue. , 2001, Clinical laboratory.

[18]  H. Minakami,et al.  Administration of interferon-α during pregnancy: effects on fetus , 2000 .

[19]  G. Woelk,et al.  Hepatitis B virus infection among pregnant women delivering at Harare Maternity Hospital, Harare Zimbabwe, 1996 to 1997. , 1999, The Central African journal of medicine.

[20]  G. Koren,et al.  Hepatitis B Vaccine in Pregnancy: Maternal and Fetal Safety , 1991, American journal of perinatology.

[21]  Y. Chawla,et al.  Prevalence of hepatitis B surface antigen in pregnant mothers and its perinatal transmission. , 1989, Transactions of the Royal Society of Tropical Medicine and Hygiene.